| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2019-11-06 |
详情>>
股本变动：
变动后总股本2410.04万股
|
| 2019-11-06 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-0.15美元,归母净利润-348.2万美元,同比去年增长-321.08%
|
| 2019-08-08 |
财报披露：
美东时间 2019-08-08 盘前发布财报
|
| 2019-08-08 |
详情>>
业绩披露：
2019年中报每股收益0.00美元,归母净利润-7.3万美元,同比去年增长-102.2%
|
| 2019-05-08 |
详情>>
业绩披露：
2019年一季报每股收益0.15美元,归母净利润349.70万美元,同比去年增长190.62%
|
| 2019-04-25 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.Election of the nine (9) nominees named in the enclosed proxy statement to the Board of Directors;
2.Advisory and non-binding vote to approve Named Executive Officer compensation;
3.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2019 fiscal year;
4.Transaction of such other business that may properly come before the 2019 Annual Meeting.
|
| 2019-02-26 |
详情>>
业绩披露：
2016年年报每股收益1.05美元,归母净利润2496.40万美元,同比去年增长-53.05%
|
| 2019-02-26 |
详情>>
业绩披露：
2018年年报每股收益-0.16美元,归母净利润-375.2万美元,同比去年增长98.51%
|
| 2018-11-07 |
详情>>
业绩披露：
2018年三季报(累计)每股收益0.07美元,归母净利润157.50万美元,同比去年增长100.67%
|
| 2018-08-08 |
详情>>
业绩披露：
2017年中报每股收益-6.44美元,归母净利润-1.48亿美元,同比去年增长-688.63%
|
| 2018-08-08 |
详情>>
业绩披露：
2018年中报每股收益0.14美元,归母净利润332.10万美元,同比去年增长102.24%
|
| 2018-07-02 |
详情>>
内部人交易：
Wang Sing等共交易7笔
|
| 2018-05-18 |
股东大会：
将于2018-06-28召开股东大会
会议内容 ▼▲
- 1.Election of the eight (8) nominees named in the enclosed proxy statement to the Board of Directors;
2.Advisory and non-binding vote to approve named executive officer compensation;
3.Approval of the 2018 Long-Term Incentive Plan;
4.Approval of the First Amendment to the 2010 Employee Stock Purchase Plan;
5.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
6.Transaction of such other business that may properly come before the 2018 Annual Meeting.
|
| 2018-05-09 |
详情>>
业绩披露：
2018年一季报每股收益-0.17美元,归母净利润-385.9万美元,同比去年增长-148.26%
|
| 2018-02-27 |
详情>>
业绩披露：
2017年年报每股收益-10.9美元,归母净利润-2.52亿美元,同比去年增长-1110.06%
|
| 2017-11-08 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-10.17美元,归母净利润-2.35亿美元,同比去年增长-741.3%
|
| 2017-04-27 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1.Election of the ten (10) nominees to the Board of Directors.
2.Advisory and non-binding vote to approve the compensation to our named executive officers.
3.Advisory and non-binding vote on frequency of vote regarding named executive officer compensation.
4.Amendment and Restatement of the 2009 Equity Incentive Plan and 162(m) performance goals.
5.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2017 fiscal year.
6.Transaction of such other business as may properly come before the 2017 Annual Meeting and any adjournment or postponement.
|
| 2016-04-25 |
股东大会：
将于2016-06-07召开股东大会
会议内容 ▼▲
- (1)Amendment to the Amended and Restated Certificate of Incorporation (the “Charter”) described in the enclosed proxy;
(2)Election of the ten (10) nominees named in the enclosed proxy statement to the board of directors;
(3)Advisory vote to approve named executive officer compensation;
(4)Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
(5)Transaction of such other business that may properly come before the 2016 Annual Meeting.
|
| 2015-04-16 |
股东大会：
将于2015-06-03召开股东大会
会议内容 ▼▲
- 1.The election of the ten nominees named in the accompanying proxy statement to the Board of Directors.
2.An advisory vote to approve named executive officer compensation.
3.The approval of the Internal Revenue Code Section 162(m)-compliant Vitamin Shoppe, Inc. Covered Employee Performance-Based Compensation Plan.
4.The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2015 fiscal year.
5.The transaction of such other business as may properly come before the annual meeting and any adjournment or postponement.
|
| 2014-04-15 |
股东大会：
将于2014-06-04召开股东大会
会议内容 ▼▲
- 1. The election of the ten nominees named in the accompanying proxy statement to the Board of Directors.
2. An advisory vote to approve named executive officer compensation.
3. The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2014 fiscal year.
4. The transaction of such other business as may properly come before the annual meeting and any adjournment or postponement.
|
| 2013-04-11 |
股东大会：
将于2013-06-05召开股东大会
会议内容 ▼▲
- 1. The election of ten members to the Board of Directors;
2. An advisory vote to approve named executive officer compensation;
3. The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2013 fiscal year;
4. The transaction of such other business as may properly come before the annual meeting and any adjournment or postponement.
|